Has COVID-19 changed the pathological outcomes in prostate cancer?
05 Aug 2021
byElvira Manzano
The likelihood of pT3* or higher tumours and node-positive disease found at the time of radical prostatectomy (RP) for prostate cancer (PCa) was greater during the COVID-19 pandemic than it was before, an expert reported at EAU21.
Has COVID-19 changed the pathological outcomes in prostate cancer?
05 Aug 2021